Direct lipolysis & adrenergic drive
One of 6 mechanistic pathways to 🔥 Lose fat · 13 options
Skip the brain and the mitochondrion and act on the fat cell itself. β-adrenergic receptors on adipocytes trigger hormone-sensitive lipase; GH fragments do something similar without the glucose consequences of full GH. Fast-acting, and the same receptors sit on your heart, which is the entire safety story of this pathway.
This pathway leans on beta-adrenergic signalling, so it stacks on top of whatever your sympathetic tone already is. High cortisol plus a stimulant is how people get palpitations, insomnia and a worse result than they started with. Check before you add adrenergic drive, not after.
Cortisol (AM)TSH (Thyroid-Stimulating Hormone)Free T3 (Triiodothyronine)hs-CRP (High-Sensitivity C-Reactive Protein)🌡️ Adrenal & Cortisol Axis covers these in one panel →
What engages this pathway
Ordered by how directly each one acts on the mechanism above — never by how much trial evidence exists. Each links to its full breakdown with dosing, half-life and vendor.
💉 AOD-9604
The C-terminal fragment of GH engineered to keep the lipolytic action and lose the IGF-1 and glucose effects. Human trials for obesity failed their weight endpoints — but the mechanism is real and the extrapolation people make is toward localised use and stacking, which was never what was tested.
💉 Clenbuterol
β2-agonist. Raises lipolysis and metabolic rate and is genuinely effective; it also raises heart rate, causes cardiac hypertrophy with chronic use, and depletes taurine. Effective is not the same as advisable.
💉 Mirabegron
β3-agonist approved for overactive bladder. β3 receptors sit on brown adipose tissue — human PET imaging shows it activates BAT and raises resting energy expenditure. This is one of the more elegant extrapolations available: an on-label drug with an off-label mechanism that actually images.
💉 Lipotropic Blend
Carnitine plus MIC plus B12 plus a small amount of albuterol. The albuterol is doing the lipolytic work; the rest is substrate support. Mind stimulant and cardiac sensitivity.
💉 Lipo-C
The lipotropic injection without the beta-agonist — methionine, inositol, choline and carnitine. Supports hepatic fat export rather than driving lipolysis.
💉 L-Carnitine
Injectable carnitine bypasses the poor oral absorption problem. Still only useful if fatty-acid transport is actually your bottleneck.
💉 Nad+/Carnitine Amino Blend
Combines the NAD+ and carnitine arguments in one vial — substrate transport plus cofactor availability.
💉 DADA
A research adrenergic-pathway compound with essentially no human characterisation. Listed for completeness; the honest position is that nobody knows.
🧬 Yohimbine
α2-antagonist. α2 receptors act as a brake on lipolysis and are densest in stubborn fat — lower body in women, lower abdomen in men. Blocking them raises regional blood flow and fat mobilisation, and the effect is strongest fasted. Anxiety and blood-pressure response are dose-limiting.
🧬 Caffeine
Phosphodiesterase inhibition and adenosine antagonism raise cAMP, which raises lipolysis, plus a real thermogenic effect. Tolerance develops to the thermogenesis faster than to the stimulation.
🧬 Paraxanthine
Caffeine's primary metabolite and the one doing much of the work. Cleaner subjective profile with less anxiogenic pressure; the fat-oxidation claim is extrapolated from caffeine's.
🧬 Green Tea (EGCG)
EGCG inhibits COMT, slowing noradrenaline breakdown so the adrenergic signal at the adipocyte lasts longer. Meta-analyses show a small but real effect, and it's synergistic with caffeine for exactly this reason.
🧬 Theacrine
Structurally close to caffeine with slower tolerance development. The lipolysis argument is by analogy rather than by trial.
The other 5 routes to lose fat
Pick the pathway that matches where you are actually stuck. An appetite drug does nothing for someone who already undereats.
Want the protocols behind these?
Dosing schedules, stacking, cycle timing and Coach Cam's notes live inside the Academy — plus the full interactive Vault.
Join the Academy — $10/mo →← Open this pathway in the interactive Vault
Frequently asked questions
Skip the brain and the mitochondrion and act on the fat cell itself. β-adrenergic receptors on adipocytes trigger hormone-sensitive lipase; GH fragments do something similar without the glucose consequences of full GH. Fast-acting, and the same receptors sit on your heart, which is the entire safety story of this pathway.
13 options are mapped to this pathway in the Vault, including AOD-9604, Clenbuterol, Mirabegron, Lipotropic Blend. They are grouped by the mechanism they act through rather than ranked by how much trial evidence exists — 5 carry clinical validation and 8 are mechanistic predictions.
This pathway leans on beta-adrenergic signalling, so it stacks on top of whatever your sympathetic tone already is. High cortisol plus a stimulant is how people get palpitations, insomnia and a worse result than they started with. Check before you add adrenergic drive, not after. The markers worth checking are Cortisol (AM), TSH (Thyroid-Stimulating Hormone), Free T3 (Triiodothyronine), hs-CRP (High-Sensitivity C-Reactive Protein).
Unproven is not the same as ineffective. Of the 13 options on this pathway, 5 have clinical validation and 8 are graded theoretical — meaning the mechanism is sound but the specific human trial has not been run, which is true of a great deal of what works in this space. Nothing on this page is ordered by evidence tier, because sorting by trial count would bury the compounds you came looking for.